Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2007

View Archived Issues

Increased immunogenicity of two novel malaria vaccine candidates in preclinical studies

Recent patents cover new therapeutic agents for cancer

Recent NeuroSearch patents disclose new antipsychotic agents

Shire reviews Q1 developments

Studies detail activity of ranibizumab in macular degeneration

Targeting the sodium pump subunits with topical siRNA may be used in treating ocular hypertension

VEGF Trap improves diabetic macular edema

AVI receives three bioterrorism contracts from DoD

Abraxis BioScience and Cenomed establish CNS joint venture

BIIB-014 begins phase II for Parkinson's disease

VASTox selects preclinical candidate for Duchenne muscular dystrophy

Bepotastine shows promise in allergic conjunctivitis

Long-term remissions of ocular Behcet's disease with interferon therapy

Novel preclinical data on immunosuppression presented at the American Transplant Congress

Approvable letter for Provenge

CellCyte signs production agreement for CCG-TH30

Second cohort completes Amorcyte's phase I cardiac cell therapy study

GMX-1777 begins phase I study in refractory solid tumors and lymphomas

Invitrogen and Cytori partner to offer adipose stem cell research products

Phase I trials begin for Oramed Insulin capsules

Bristol-Myers Squibb and Isis collaborate on antisense drugs targeting PCSK9

P&G terminates Hedgehog agonist hair growth collaboration with Curis

FDA Advisory Committee votes against Junovan

Meda acquires European rights to omeprazole/ketaprofen combination product

Panflu cleared for phase II testing in China

Favorable release profile of extended-release morphine sulfate plus sequestered naltrexone

FDA approves Neupro for early Parkinson's disease

Taiho files for Japanese approval for Zosyn

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...